Protein Therapeutics Market, by Therapeutic Proteins (Monoclonal Antobodies (mAbs), Erythropoietin (EPO), Insulin, Interferon (IFN), Human Growth Hormone (HGH), Follicle Stimulating Hormone (FSH), Blood Clotting Factors) – Global Revenue, Trends, Growth, Share, Size, and Forecast To 2022

Protein therapeutics market is set to grow in the forecast period as its demand is increasing and there's increase in the investment on this market. Protein therapeutics is helpful in rare, life-threatening, and genetic diseases. North America and Europe are the top consumers of protein therapeutics because of better healthcare infrastructure and rise of chronic diseases among their citizens. Asia-Pacific is supposed to have a good growth rate in future for the protein therapeutics market because of large population and improving income levels.

The report on the global Protein therapeutics market uses the top-down and bottom-up approaches to define, analyze, and describe the market trends for the next five years. The report also tracks the emerging applications, innovative technologies, and mergers & acquisitions. It also focuses on the growth drivers and restraints for the key market players during the forecast period.

KEY BENEFITS OF THE REPORT

• In-depth analysis of the market ecosystem and its impact on the revenue growth
• Understanding of the strategies that are being adopted by the key players in this market to stay competitive
• Valuable insights into the key technological and market trends impacting this market

KEY PREMIUM INDUSTRY INSIGHTS

• The key reasons for the growth of protein therapeutics market are favorable regulations, technological advancements in the field of healthcare, increasing geriatric population, and increase in the chronic diseases such as diabetes, cancer, and cardiovascular diseases.
• Rise in the government expenditure on healthcare in developing economies is one of the key growth opportunities in the protein therapeutics market.

• However, the protein therapeutics market will be hampered by the cost of production and the side effects.

RESEARCH METHODOLOGY

The research methodology for Scalar Market Research’s protein therapeutics market report utilizes a combination of top-down and bottom-up research formats. Our primary focus on continuous market tracking, rigorous fact-checking, data-triangulation, and multiple layers of quality control ensures high-quality data that can be leveraged for actionable research insights.

To know about the assumptions considered for the study, Download PDF Sample.

MARKET SEGMENTATION

This report analyzes the protein therapeutics market by the following segments:

• Protein Therapeutics Market, by Therapeutic Proteins
  • Monoclonal Antobodies (mAbs)
  • Erythropoietin (EPO)
  • Insulin
  • Interferon (IFN)
  • Human Growth Hormone (HGH)
  • Follicle Stimulating Hormone (FSH)
  • Blood Clotting Factors

KEY MARKET PLAYERS

Key players in the protein therapeutics market include:

• Novo Nordisk
• Johnson & Johnson
• Eli Lilly & Company
• Roche
• Group Biogen Idec Inc.
• Sanofi-Aventis
• Merck Serono S.A.
• Amgen Inc.
• Abbott Laboratories
• Pfizer

GEOGRAPHIC COVERAGE AND ANALYSIS

This granular market research report covers the following geographic regions in great detail:

• NORTH AMERICA
  • U.S.
  • Rest of North America
• EUROPE
  • France
  • Germany
  • U.K.
  • Rest of Europe
• ASIA-PACIFIC
  • China
  • India
  • Japan
  • Rest of Asia-Pacific
• MIDDLE EAST & AFRICA
  • GCC
  • North Africa
  • South Africa
  • Rest of Middle East & Africa
• LATIN AMERICA
  • Brazil
  • Rest of Latin America

TRENDING RELATED REPORT

Molecular Diagnostics Market, by Products (Reagents, Consumables, Instruments, Systems), Technologies (PCR, INAAT, Microarrays, Immunochemical, Sequencing), Applications (Infectious Diseases, Oncology, Genetic Testing, Blood Screening, Microbiology) - Global Revenue, Trends, Growth, Share, Size and Forecast to 2022